ICAR plays a vital role in achieving government\'s vision of doubling farmers’ income by 2022: Union Agri Minister

2018-07-17 10:27:54

Union Minister Singh expressed happiness and said that due to the techniques developed by ICAR and hard work of the farmers, foodgrain production touched 275.68 million tonnes this year.

By Team ABLE

At the recently held ICAR’s 90thFoundation day and award ceremony function in New Delhi on July 16th, Union Minister of Agr

Read more

Deaths from cardiovascular disease rising in India: Dr. Prabhat Jha’s study report

2018-07-17 10:22:59

A study published in The Lancet Global Health suggests that death due to cardiovascular disease is on the rise in India, affecting rural populations and young adults. By Team ABLEDeath due to cardiovascular disease is on the rise in India, causing more than one quarter of all deaths in the country in 2015 and affecting rural populations and young adults the most, suggests a study published in

Read more

Inj Voveran Banned: Drug regulator cancels licence for Diclofenac sold by Novartis

2018-07-17 10:19:39

The Drug Controller General of India (DCGI) further ordered for the withdrawal of the drug’s stock from the market.New Delhi: India’s drug regulator has enforced a ban on the manufacture and sale of painkiller injection, Diclofenac, made by Themis Medicare and marketed by Novartis India Ltd under the brand name Inj Voveran 1ml, after a Health Ministry panel raised concerns over the medicine’

Read more

Mitra RxDxraises $40 million from Northpond Ventures

2018-07-17 10:02:29

Mitra RxDx (dba Mitra Biotech) has raised $40 million in a financing round led by Northpond Ventures.By Team ABLEMitra RxDx (dba Mitra Biotech) has raised $40 million in a financing roundled by Northpond Ventures, headquartered in Bethesda, Maryland. Existing investors Accel, Sequoia Capital, Sands Capital Ventures, and RA Capital Management also participated in this round. Cumulative funding to d

Read more

Otsuka Pharmaceutical acquires Visterrafor $430 million

2018-07-17 10:00:13

Following completion of the acquisition, Visterra will be a wholly owned subsidiary of Otsuka America, which is a U.S. holding company and a wholly owned subsidiary of Otsuka Pharmaceuticalof Japan.By Team ABLEJapanese drug manufacturer, Otsuka Pharmaceutical and US-located Visterra have entered into a definitive merger agreement pursuant to which Otsuka will acquire Visterra for approximately $43

Read more

MTaI to organize seminar on medical packaging; DuPont to educate audience on new rules in Europe

2018-07-17 09:58:41

The seminar entitled MTaI Medical Packaging Seminar, will be organized on July 16, 2018 in New Delhi. The seminar will be focused on Sterile Medical Packaging Regulatory and Standards Review requirements after the new EU MDR, as well as Packaging Engineering and Design, Peel Strength & Microbial Barrier, etc. By Team ABLEMedical Technology Association of India (MTaI), an association of re

Read more

Mortality rate three times higher in Indians with diabetes compared to Indians without diabetes: MDRF CURES 2018 study

2018-07-17 09:56:13

The excess mortality due to diabetes was most marked in the age group of 51-70 years. Most of this excess mortality due to diabetes was accounted for by renal disease and cardiovascular disease. By Team ABLEThe Madras Diabetes Research Foundation (MDRF) has published a study report focusing solely on the mortality rates among Indians with and without diabetes. A brainchild of Dr. R M Anjanaan

Read more

Kenya approves Mahyco to import GMO cotton seeds

2018-07-17 09:53:59

Kenya has licensed India-based firm Maharashtra Hybrid Seeds Co (Mahyco) to import genetically modified cotton seeds for sale to local farmers after the ongoing field trials.By Team ABLEAccording to a news filed on Business Daily Africa’s website,Kenya has licensed India-based firm Maharashtra Hybrid Seeds Co (Mahyco) to import genetically modified cotton seeds for sale to local farmers after th

Read more

Alabama University researchers discover how tuberculosis bacteria escapes death in macrophages

2018-07-17 09:50:59

The mechanism the tuberculosis pathogen uses in its escape suggests possible therapies to improve patient outcomes

By Team ABLE

The bacteria that cause the devastating disease tuberculosis have the ability to escape destruction and grow after they are engulfed by lung macrophages, the immune cells that are supposed to destr

Read more

Glenmark launches Swiss Pharma company’s cancer drug in India

2018-07-17 09:46:50

Glenmark\nwill launch Helsinn’s AKYNZEO, a fixed dose combination drug for the prevention\nof CINV (chemotherapy-induced nausea and vomiting) in the Indian market.

\n\n

By Team ABLE

\n\n

Glenmark Pharmaceuticals and Swiss\npharmaceutical group Helsinn have announced the launch of AKYNZEO, a fixed dose\ncombination drug for

Read more